Bank of New York Mellon Corp - GLYCOMIMETICS INC ownership

GLYCOMIMETICS INC's ticker is GLYC and the CUSIP is 38000Q102. A total of 81 filers reported holding GLYCOMIMETICS INC in Q2 2019. The put-call ratio across all filers is 145.50 and the average weighting 0.2%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of GLYCOMIMETICS INC
ValueSharesWeighting
Q3 2023$37,313
-14.6%
24,875
-0.9%
0.00%
Q2 2023$43,690
+37.7%
25,109
-0.3%
0.00%
Q1 2023$31,717
-60.0%
25,172
-3.8%
0.00%
Q4 2022$79,289
+466.4%
26,168
-0.3%
0.00%
Q3 2022$14,000
-12.5%
26,2380.0%0.00%
Q2 2022$16,000
-46.7%
26,238
-0.2%
0.00%
Q1 2022$30,000
-21.1%
26,2990.0%0.00%
Q4 2021$38,000
-34.5%
26,2990.0%0.00%
Q3 2021$58,000
-6.5%
26,299
-1.4%
0.00%
Q2 2021$62,000
-84.9%
26,664
-80.4%
0.00%
Q1 2021$410,000
-17.3%
136,337
+3.1%
0.00%
Q4 2020$496,000
+24.9%
132,232
+2.3%
0.00%
Q3 2020$397,000
-16.2%
129,219
+2.4%
0.00%
Q2 2020$474,000
+70.5%
126,207
+3.5%
0.00%
Q1 2020$278,000
-53.5%
121,911
+7.9%
0.00%
Q4 2019$598,000
+1.0%
113,032
-17.7%
0.00%
Q3 2019$592,000
-66.0%
137,280
-6.0%
0.00%
Q2 2019$1,741,000
-4.6%
145,991
-0.3%
0.00%
-100.0%
Q1 2019$1,824,000
+33.6%
146,362
+1.5%
0.00%
Q4 2018$1,365,000
-33.0%
144,163
+1.9%
0.00%
-100.0%
Q3 2018$2,036,000
-8.8%
141,445
+2.2%
0.00%0.0%
Q2 2018$2,232,000
+302.9%
138,378
+305.4%
0.00%
Q1 2018$554,000
-62.4%
34,130
-61.1%
0.00%
Q4 2017$1,472,000
+12.2%
87,695
-6.5%
0.00%
Q3 2017$1,312,000
+26.5%
93,769
+0.9%
0.00%
Q2 2017$1,037,000
+431.8%
92,911
+159.4%
0.00%
Q1 2017$195,000
-11.0%
35,8200.0%0.00%
Q4 2016$219,000
-12.0%
35,820
+2.9%
0.00%
Q3 2016$249,000
+15.3%
34,802
+17.0%
0.00%
Q2 2016$216,000
-35.5%
29,746
+44.9%
0.00%
Q1 2014$335,00020,5320.00%
Other shareholders
GLYCOMIMETICS INC shareholders Q2 2019
NameSharesValueWeighting ↓
BVF INC/IL 3,229,856$45,186,0005.74%
NEA Management Company, LLC 8,584,128$120,092,0004.21%
NEXTHERA CAPITAL LP 321,286$4,495,0001.16%
Redmile Group, LLC 1,214,088$16,985,0000.84%
EAM Investors, LLC 371,030$5,191,0000.69%
Schonfeld Strategic Advisors LLC 500,104$6,996,0000.64%
ELEMENT CAPITAL MANAGEMENT LLC 29,909$418,0000.17%
Jafra Capital Management LP 16,839$236,0000.09%
PRENTISS SMITH & CO INC 20,000$280,0000.08%
Endurant Capital Management LP 17,607$246,0000.08%
View complete list of GLYCOMIMETICS INC shareholders